In nearly all cases, the Phase III protocol had a higher number of endpoints, procedures, and eligibility criteria relative ...
In an industry driven by scientific curiosity and innovation, the notion that too much data could be a drawback is almost ...
CARY, N.C., Aug. 25, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of WCG Total Training, the ...
TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying clinical research, today shared progress ...
If followed, clinical trial protocols established during the COVID-19 pandemic could allow more patients participate. The COVID-19 pandemic caused a major shift in the way that health care was ...
"Sponsors should design failure into clinical trials to support patients" was originally created and published by Clinical ...
SHELTON, CT / ACCESS Newswire / July 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of ...
In the past few years, the healthcare world has faced some of its toughest challenges the COVID-19 pandemic was a wake up call for everyone especially for those involved in clinical trials many trials ...
The COVID-19 pandemic is halting and slowing down clinical trials, and the Food and Drug Administration is offering guidelines to adjust to these new challenges. Clinical trials may slow, stop or ...
Over the past several years, the number of deviations and substantial amendments made to clinical trial protocols has increased notably, contributing to delays in drug development and rising costs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback